Collectively, our findings indicate that ANKS1A regulates LRP1-mediated Aβ clearance across the BBB and a reduced ANKS1A function is a risk factor for CAA-associated AD pathogenesis (Supplementary Fig. 8). This evidence concerns the gene ANKS1A and Alzheimer disease.